Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Daxor (DXR) Stock Price & Analysis

DXR Stock Chart & Stats

$9.20$0.28(3.14%)
At close: 4:00 PM EDT
$9$10$113 Aug17 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
$8.40 - $9.20
52-Week Range
$8.40 - $14.76
Previous Close
$8.92
Volume
2,174
Average Volume (3M)
14.61K
Market Cap
$53.71M
Enterprise Value
$45.53M
Total Cash (Recent Filing)
$5.79M
Total Debt (Recent Filing)
$0
Price to Earnings (P/E)
7.5
Beta
0.62
Next Earnings
Mar 10, 2027 (Est.)
EPS Estimate
N/A
Last Dividend Ex-Date
Jan 05, 2018
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Very Low Leverage

Minimal debt and a substantial equity cushion reduce financial strain and preserve flexibility for product development, commercialization, and clinical adoption efforts. This balance-sheet resilience can help Daxor fund operations through periods of uneven revenue without relying heavily on refinancing or new borrowing.

Specialized Medical Technology

A focused blood-volume measurement platform gives Daxor a defined position within medical devices and diagnostics rather than a broad, unfocused product portfolio. Its use in clinically important fluid-status decisions supports the potential for durable relevance if clinicians continue adopting the technology.

Reported High Margins

Very high reported operating and net margins indicate that the business can produce substantial accounting profitability in favorable periods. Although the revenue base is volatile and results may include irregular items, this margin profile suggests the technology can carry meaningful earnings potential when sales are realized.

Bears Say

Severe Revenue Volatility

Sharp swings in annual sales make it difficult to establish a dependable growth trajectory or forecast near-term operating performance. This volatility can disrupt commercialization planning, reduce confidence in recurring demand, and make reported earnings less representative of sustainable business scale.

Weak Cash Conversion

Repeated negative operating and free cash flow show that accounting profitability has not consistently translated into internally generated cash. Continued cash burn could constrain investment in development and commercialization, while also increasing reliance on the existing balance-sheet cushion to fund execution.

Unstable Earnings Quality

Inconsistent revenue and margin patterns weaken confidence that the latest strong profitability reflects a repeatable operating model. If earnings depend materially on irregular items rather than stable sales execution, future results may remain difficult to predict and less durable over several reporting periods.

Daxor News

DXR FAQ

What was Daxor’s price range in the past 12 months?
Daxor lowest stock price was $8.40 and its highest was $14.76 in the past 12 months.
What is Daxor’s market cap?
Daxor’s market cap is $53.71M.
When is Daxor’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Daxor’s earnings last quarter?
Daxor released its earnings results on Aug 20, 2026. The company reported -$0.06 earnings per share for the quarter, missing the consensus estimate of -$0.03 by -$0.03.
Is Daxor overvalued?
According to Wall Street analysts Daxor’s price is currently Undervalued.
Does Daxor pay dividends?
Daxor pays a Monthly dividend of $0.03 which represents an annual dividend yield of ―. See more information on Daxor dividends here
What is Daxor’s EPS estimate?
Daxor’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Daxor have?
Daxor has 5,838,224 shares outstanding.
What happened to Daxor’s price movement after its last earnings report?
Daxor reported an EPS of -$0.06 in its last earnings report, missing expectations of -$0.03. Following the earnings report the stock price went down -2.621%.
Which hedge fund is a major shareholder of Daxor?
Currently, no hedge funds are holding shares in DXR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology